Pharmaceutical firm Schering has received marketing approval for its liver-specific MRI contrast agent Resovist in Japan. The product, which received European Union market approval in 2001, will be distributed by Nihon Schering KK after it has received a Japanese national healthcare insurance price listing.
By AuntMinnie.com staff writersOctober 10, 2002
Related Reading
Schering sales, earnings climb, February 5, 2002
Schering buys rest of CIS bio, January 3, 2002
Schering gets approval for Resovist in Sweden, March 28, 2001
Schering gains Japanese rights to Epix’s MS-325, January 9, 2001
Copyright © 2002 AuntMinnie.com